相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Anion binding in water at lanthanide centres: from structure and selectivity to signalling and sensing
Stephen J. Butler et al.
CHEMICAL SOCIETY REVIEWS (2013)
A Folding-Based Approach for the Luminescent Detection of a Short RNA Hairpin
Cristina Penas et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
In vitro cell imaging using multifunctional small sized KGdF4:Yb3+,Er3+ upconverting nanoparticles synthesized by a one-pot solvothermal process
Hon-Tung Wong et al.
NANOSCALE (2013)
Europium (III) complexes with new N-donor ligand: A comparative study in solid state and solution
Fabio Piccinelli et al.
POLYHEDRON (2013)
Intriguing aspects of lanthanide luminescence
Jean-Claude G. Buenzli et al.
CHEMICAL SCIENCE (2013)
Enabling and Disabling Polo-like Kinase 1 Inhibition through Chemical Genetics
Mark E. Burkard et al.
ACS CHEMICAL BIOLOGY (2012)
Polo-Like Kinases Inhibitors
L. Garuti et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Luminescent lanthanide-binding peptides: sensitising the excited states of Eu(III) and Tb(III) with a 1,8-naphthalimide-based antenna
Celia S. Bonnet et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs) and its downregulation promotes cell cycle arrest and apoptosis
Minakshi Nihal et al.
CELL CYCLE (2011)
Two-photon induced responsive f-f emissive detection of Cyclin A with a europium-chelating peptide
Hoi-Kwan Kong et al.
CHEMICAL COMMUNICATIONS (2011)
Peptides or Small Molecules? Different Approaches to Develop More Effective CDK Inhibitors
D. Cirillo et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival
Quyen T. Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
siRNA delivery systems for cancer treatment
Yu-Kyoung Oh et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Nonblinking and Nonbleaching Upconverting Nanoparticles as an Optical Imaging Nanoprobe and T1 Magnetic Resonance Imaging Contrast Agent
Yong Il Park et al.
ADVANCED MATERIALS (2009)
Cyclin A probes by means of intermolecular sensitization of terbium-chelating peptides
Elena Pazos et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Assessing the delivery efficacy and internalization route of cell-penetrating peptides
Samir El Andaloussi et al.
NATURE PROTOCOLS (2007)
Synthesis of polyethylenimine/NaYF4 nanoparticles with upconversion fluorescence
Feng Wang et al.
NANOTECHNOLOGY (2006)
REPLACE: A strategy for iterative design of cyclin-binding groove inhibitors
Martin J. I. Andrews et al.
CHEMBIOCHEM (2006)
Therapeutic potential of RNA interference against cancer
Fumitaka Takeshita et al.
CANCER SCIENCE (2006)
Phosphorylation state-responsive lanthanide peptide conjugates:: A luminescence switch based on reversible complex reorganization
Matthew S. Tremblay et al.
ORGANIC LETTERS (2006)
Modulation of luminescence intensity of lanthanide complexes by photoinduced electron transfer and its application to a long-lived protease probe
Takuya Terai et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption
Takehiko Shiraishi et al.
NATURE PROTOCOLS (2006)
Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis
MW Landis et al.
CANCER CELL (2006)
Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis
HKDL Reddy et al.
CANCER RESEARCH (2005)
RNA interference as a gene-specific approach for molecular medicine
A Grunweller et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Insights into cyclin groove recognition: Complex crystal structures and inhibitor design through ligand exchange
G Kontopidis et al.
STRUCTURE (2003)
Highly potent p21WAF1-derived peptide inhibitors of CDK-mediated pRb phosphorylation:: Delineation and structural insight into their interactions with cyclin A
DI Zheleva et al.
JOURNAL OF PEPTIDE RESEARCH (2002)